This website uses cookies and similar technologies (hereinafter collectively referred to as ‘cookies’). We may use cookies for the following purposes:
With the buttons below, you can choose which cookies you wish to accept. On our cookie statement page, you can manage your cookie preferences. You can always withdraw your consent for cookies by making different choices there. For more information about cookies, please refer to our cookie statement.
Several change agents and their impact in the medical industry are outlined. One of whom is MBA alumnus Marianne D. De Backer has contributed significantly building a robust infectious disease pipeline for Johnson & Johnson Innovation.
Several change agents and their impact in the medical industry are outlined. One of whom is MBA alumnus Marianne D. De Backer has contributed significantly building a robust infectious disease pipeline for Johnson & Johnson Innovation.